JELMYTO

MITOMYCIN · UroGen Pharma, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for JELMYTO, covering 2020-04-15 to 2025-02-28. Get the full timeline:

Most recent: Clinical Trial Update: uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto